Microbot Medical Inc. financial data

Symbol
MBOT on Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
Location
25 Recreation Park Dr Suite 108, Hingham, MA
State of incorporation
DE
Fiscal year end
December 31
Former names
STEMCELLS INC (to 11/15/2016), CYTOTHERAPEUTICS INC/DE (to 5/15/2000)
Latest financial report
10-Q - Q3 2024 - Nov 13, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 352 % -35%
Debt-to-equity 38 % +68%
Return On Equity -218 % -49.3%
Return On Assets -158 % -32.7%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 16.9M shares +44.6%
Common Stock, Shares, Outstanding 16.7M shares +42.2%
Entity Public Float 38.1M USD +10.5%
Common Stock, Value, Issued 168K USD +42.4%
Weighted Average Number of Shares Outstanding, Basic 16.5M shares +40.7%
Weighted Average Number of Shares Outstanding, Diluted 16.5M shares +40.7%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 5.78M USD -10.8%
General and Administrative Expense 4.49M USD +2.51%
Operating Income (Loss) -10.3M USD +5.45%
Net Income (Loss) Attributable to Parent -11.2M USD -5.87%
Earnings Per Share, Basic -0.77 USD/shares +35.8%
Earnings Per Share, Diluted -0.77 USD/shares +4.76%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 479K USD -64.1%
Marketable Securities, Current 3.86M USD -43.4%
Cash, Cash Equivalents, and Short-term Investments 4.34M USD -46.8%
Other Assets, Current 1.34M USD
Assets, Current 5M USD -40.6%
Property, Plant and Equipment, Net 99K USD -46.2%
Operating Lease, Right-of-Use Asset 114K USD -61.6%
Assets 5.21M USD -41.4%
Accounts Payable, Current 246K USD +3.36%
Employee-related Liabilities, Current 725K USD -47.2%
Accrued Liabilities, Current 1.06M USD +1.24%
Liabilities, Current 1.37M USD -8.05%
Operating Lease, Liability, Noncurrent 29K USD -25.6%
Liabilities 1.4M USD -8.5%
Retained Earnings (Accumulated Deficit) -87.6M USD -14.7%
Stockholders' Equity Attributable to Parent 3.81M USD -48.2%
Liabilities and Equity 5.21M USD -41.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -2.42M USD +24.4%
Net Cash Provided by (Used in) Financing Activities 2.4M USD
Net Cash Provided by (Used in) Investing Activities -1.28M USD -145%
Common Stock, Shares Authorized 60M shares 0%
Common Stock, Shares, Issued 16.7M shares +42.2%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -1.31M USD -308%
Interest Paid, Excluding Capitalized Interest, Operating Activities 40K USD +14.3%
Deferred Tax Assets, Valuation Allowance 116M USD +2.26%
Deferred Tax Assets, Gross 116M USD +2.47%
Operating Lease, Liability 231K USD -50%
Payments to Acquire Property, Plant, and Equipment 14K USD
Lessee, Operating Lease, Liability, to be Paid 277K USD -44%
Property, Plant and Equipment, Gross 639K USD +5.1%
Operating Lease, Liability, Current 65K USD -68.4%
Lessee, Operating Lease, Liability, to be Paid, Year Two 48K USD -73.5%
Lessee, Operating Lease, Liability, to be Paid, Year One 208K USD -33.3%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure -22.2%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 47K USD +42.4%
Lessee, Operating Lease, Liability, to be Paid, Year Three 21K USD +950%
Deferred Tax Assets, Operating Loss Carryforwards 116M USD +2.1%
Operating Lease, Payments 75K USD -19.4%
Depreciation, Depletion and Amortization 28K USD +12%
Deferred Tax Assets, Net of Valuation Allowance 357K USD +213%